Status:

COMPLETED

12 Versus 20 mL PCB for D&E Cervical Prep

Lead Sponsor:

Stanford University

Conditions:

Pain

Eligibility:

FEMALE

18+ years

Phase:

PHASE4

Brief Summary

More research is needed to investigate methods of pain control for cervical preparation for abortion procedures. Women report pain with paracervical block injection as well as with osmotic dilator pla...

Detailed Description

This is a non-inferiority, single blinded, randomized controlled trial.This study will use a 2-site, 12 mL 1% plain lidocaine injection paracervical block (PCB) technique (2 mL for tenaculum placement...

Eligibility Criteria

Inclusion

  • Women 18 and older
  • Intrauterine pregnancy ≥16 weeks gestation
  • English speaking competency
  • Willing and able to sign consent forms
  • Agree to comply with study procedures

Exclusion

  • Women less than 18 years of age
  • IV conscious sedation
  • Known allergy to study medication (lidocaine)
  • Any women not meeting inclusion criteria above will be excluded from participation

Key Trial Info

Start Date :

January 1 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 15 2020

Estimated Enrollment :

96 Patients enrolled

Trial Details

Trial ID

NCT03356145

Start Date

January 1 2017

End Date

October 15 2020

Last Update

January 23 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Stanford University

Stanford, California, United States, 94305